LCTX Lineage Cell Therapeutics, Inc.

NEUTRAL Impact: 4/10 EFFECT
Horizon weeks Filed Mar 24, 2026 Processed 2mo ago SEC 9999999995-26-000908
IPO/offering going effective
Latest settled — T+20d
LCTX ▲ +10.14% at T+20d
NEUTRAL call ✓ call won +10.14% · α vs SPY +1.23% · entry $1.48 → $1.63
Next anchor: T+60d in 8d
Last close $1.21 (close Jun 8) · -18.24% from $1.48 entry
Entry anchored
Mar 23, 03:59 PM ET
via Databento tick
T+1d
+4.73%
call +4.73% · α +4.16%
$1.55
settled 3mo ago
T+5d
+6.76%
call +6.76% · α +7.18%
$1.58
settled 2mo ago
T+20d
+10.14%
call +10.14% · α +1.23%
$1.63
settled 7w ago
T+60d
call — · α —
in 8d

Price Chart

Loading chart...

Executive Summary

Lineage Cell Therapeutics' shelf registration (Form S-3) has become effective, allowing the company to sell unspecified securities from time to time. This creates a potential for future dilution but does not specify the size, timing, or type of offering.

Actionable Insight

Monitor for future prospectus supplements that will disclose specific offering terms, including size, price, and use of proceeds. The lack of immediate capital raise suggests no urgent funding need, but the door is now open for opportunistic financing.

Key Facts

  • Form S-3 shelf registration became effective on March 23, 2026.
  • The filing allows for the issuance of unspecified amounts of common stock, preferred stock, debt securities, or warrants.
  • No specific offering size, pricing, or use of proceeds details were disclosed in this notice.
  • The company can now access capital markets at its discretion, subject to market conditions.

Financial Impact

Potential future dilution or debt issuance; magnitude unknown at this time

dilutiondebtequity

Risk Factors

  • Future equity issuance could lead to shareholder dilution.
  • Market perception of potential dilution may weigh on stock price near-term.

Market Snapshot

Exchange
NYSE

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-000908
Document: 9999999995-26-000908-index.html9999999995-26-000908
Document: 9999999995-26-000908.txt9999999995-26-000908
3 reports for LCTX
Performance horizon
Filters
Rows
Reports for LCTX — sortable, filterable
Type Now
May 12, 2026
28d ago
8-K
NEUTRAL ★ 3/10
$1.28 $1.20▼ −6.25%▼ −5.09%$1.21 (−5.47%)
Mar 24, 2026
11w ago
EFFECT
NEUTRAL ★ 4/10
$1.48 $1.58▲ +6.76%▲ +7.18%$1.21 (−18.24%)
Mar 5, 2026
13w ago
8-K
MIXED ★ 6/10
$1.85 $1.61▼ −12.97%▼ −11.44%$1.21 (−34.59%)
Showing 3 of 3

US Market Status

Market Closed — Opens in 6h 59m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access